| Why proliferative vitreoretinopathy occurs? | Ali Hakan DURUKAN | 155–159 |
| Lensectomy procedures in proliferative vitreoretinopathy | Melih ÜNAL,Eyüp DÜZGÜN | 160–165 |
| Is pharmacotherapy effective for the treatment of proliferative vitreoretinopathy? | Nur ACAR | 166–177 |
| The long term results of ranibizumab therapy results in age-related macular degeneration | Güner ÜNEY ÖZKAN,Nurten ÜNLÜ,MEHMET AKİF ACAR,Dicle HAZIROLAN,Züleyha AKKAYA YALNIZ,Firdevs ÖRNEK | 178–182 |
| Makülanın tutulduğu regmatojen retina dekolmanında görsel sonuçlar ve ilişkili faktörler | Ebru Nevin ÇETİN,Clayton SCANLON,Sandeep SAXENA,Levent AKDUMAN | 183–188 |
| The evaluation of central macular and choroidal thickness in myopic subjects with spectral-domain optical coherence tomography | Neslihan SİNİM,Çağatay KARACA,Deniz DEMİREL,OSMAN AHMET POLAT,Ayşe ÖNER | 189–192 |
| Ön üveitli gözlerde maküler kalınlaşma | Veysi ÖNER,Kemal TÜRKYILMAZ,Ayşegül TÜRKYILMAZ KÜÇÜKALİ,BERRAK ŞEKERYAPAN GEDİZ,Mustafa DURMUŞ | 193–196 |
| Silikon yağı tamponadı kullanılan maküla deliği cerrahisinin anatomik ve görsel sonuçları | BERKER BAKBAK,BANU TURĞUT ÖZTÜRK,ŞABAN GÖNÜL,ŞANSAL GEDİK | 197–200 |
| The effect of ıntravitreal bevacizumab ınjection in treatment of diabetic macular edema | Erdinç CEYLAN,Utku LİMON,Barış YENİAD,Koray AKARÇAY,NUR KIR,Tunç OVALI | 201–204 |
| Intravitreal bevacizumab for retinopathy of prematurity to save macula | MEHMET CÜNEYT ÖZMEN,Süleyman KARAATLI,Esad KÖKLÜ | 205–208 |
| Complications of encircling scleral buckling for retinal detachment surgery | Hülya EROĞLU YAZICI,Feride Aylin KANTARCI GÜN,Şengül ÖZDEK,Berati HASANREİSOĞLU | 209–212 |
| Intravitreal ocriplasmin treatment in stage 2 macular hole due to vitreomacular traction | Ali Osman SAATÇİ,SİBEL KADAYIFÇILAR,Aylin YAMAN,Zeynep ÖZBEK,Bora ELDEM | 213–215 |
| Central retinal artery occlusion following medical abortion for fetal death |